ACLS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Axcelis Technologies Inc (ACLS) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the stock has some positive momentum in post-market trading and a merger with Veeco Instruments that could enhance competitiveness, the company's recent financial performance shows significant declines in revenue, net income, and EPS. Additionally, there are no strong trading signals or significant positive catalysts to justify immediate action. A hold strategy is recommended until more clarity emerges from the upcoming earnings report or regulatory approval of the merger.
The MACD is positive and expanding, indicating mild bullish momentum. RSI is neutral at 59.154, and moving averages are converging, suggesting no clear trend. The stock is trading near its resistance level of R1: 92.701, with support at S1: 81.107.
Shareholders approved the merger with Veeco Instruments, which could enhance competitiveness in the semiconductor industry. The post-market price increase of 4.36% suggests some positive sentiment.
Significant declines in financial performance for Q3 2025, including a 16.74% drop in revenue and a 46.50% drop in net income YoY. Regulatory approval from Chinese authorities for the merger is still pending, creating uncertainty.
In Q3 2025, revenue dropped to $213.6M (-16.74% YoY), net income dropped to $25.99M (-46.50% YoY), EPS dropped to $0.83 (-44.30% YoY), and gross margin fell to 41.57% (-3.01% YoY).
B. Riley analyst Craig Ellis raised the price target to $94 from $84 with a Neutral rating. The analyst expects Q4 2025 results and Q1 2026 guidance to be in-line to slightly above consensus, but notes risks related to the Chinese market.
